What is the current stock price of GeneThera, Inc. (GTHR)?

As of the latest market data, GeneThera, Inc. (GTHR) is trading at $0.00. The stock has seen a gain of 0.00% today.

Does GeneThera, Inc. (GTHR) pay a dividend?

Based on current data, GeneThera, Inc. does not have a confirmed active dividend policy.

What is the market cap of GeneThera, Inc.?

The current market capitalization of GeneThera, Inc. (GTHR) is approximately unavailable.

GTHR

GeneThera, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.01

Company Profile

GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. It offers treatments for zoonotic diseases, such as COVID -19 disease; paratuberculosis (Johne's disease) that is in Stage III clinical phase; mad cow and chronic wasting diseases; and E.coli and salmonella infections, as well as develops vaccine for mycobacterium avium sub paratuberculosis bacteria. The company's Molecular Robotic/AI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. GeneThera, Inc. is based in Westminster, Colorado.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2012-09-25

Beta

0.81

Websitewww.genethera.net↗